Table 1.
Clinicopathological characteristics of LUAD patients from TCGA and GSE68571 databases.
| Characteristics | TCGA-LUAD cohort N=504 | GSE68571 N=86 |
|---|---|---|
| Age | ||
| <=65 | 238 (47.22%) | 50 (58.14%) |
| >65 | 256 (50.79%) | 36 (41.86%) |
| Unknow | 10 (1.99%) | 0 (0.00%) |
| Gender | ||
| Female | 270 (53.57%) | 51 (59.30%) |
| Male | 234 (46.43%) | 35 (40.70%) |
| Stage | ||
| I-II | 389 (77.17%) | NA |
| III-IV | 107 (21.24%) | NA |
| Unknow | 8 (1.59%) | NA |
| T | ||
| T0-T2 | 437 (86.70%) | NA |
| T3-T4 | 64 (12.70%) | NA |
| Unknow | 3 (0.60%) | NA |
| M | ||
| M0 | 335 (66.47%) | NA |
| M1 | 25 (4.96%) | NA |
| Unknow | 144 (28.57%) | NA |
| N | ||
| N0-N1 | 419 (83.13%) | NA |
| N2-N3 | 73 (14.49%) | NA |
| Unknow | 12 (2.38%) | NA |
| Survival status | ||
| Alive | 321 (63.69%) | 62 (72.09%) |
| Dead | 183 (36.31%) | 24 (27.91%) |
|
The median follow-up time
(year) |
1.84 | 2.42 |